Push to align MBS rebate for liver fibrosis test A new application for liver scanning technology proposes a rebate of $101.70 in general practice and $141.75 for non-GP specialists.
Novel blood test predicts kidney disease A blood test for detecting risk of developing diabetic kidney disease is now available in Australia, but a GP expert raises some concerns.
‘The system let him down’ One mother shares the story of her son who died aged 26 from long-term effects of alcohol, saying there were failings in the health system to connect him with appropriate care.
‘Almost untreatable’ superbug linked to common antibiotic In a way ‘never seen before’, one antibiotic has been found to be driving resistance to another and exposing patients to superbugs.
Understanding the Intricacies of LFTs in Clinical Practice Dr Chanika Ariyawansa, who holds significant roles in the Australian Association of Clinical Biochemistry, delves into the nuances of liver function tests, exploring patterns and the implications of abnormal results.
Responding to requests for unnecessary tests SPONSORED: There is a good reason why the word ‘necessary’ often appears when it comes to the provision and funding of medical services.
Research provides hope for type 1 diabetes ‘cure’ Further trials are needed, but the use of rare cancer drugs to assist in restoring insulin production is showing promise.
Future asthma risk flagged for babies with food allergy Even if the allergy is outgrown, poorer lung function outcomes are more likely by six years of age, a world-first study finds.
At-home bowel cancer screening could reduce colonoscopy need Research suggests faecal immunochemical tests can safely personalise cancer surveillance and lower associated healthcare costs.
Another rapid antigen test sponsor fined by the TGA An Australian company and two of its officers have also been ordered to pay $96,000 for the unlawful importation of surgical face masks.